Experts discuss the latest advances in the diagnosis and treatment of prostate cancer in Granada
The conference has analysed the latest advances in the diagnosis and treatment of prostate cancer, with a focus on personalised medicine and multidisciplinary collaboration between healthcare professionals in Granada.
The Granada Biosanitary Research Institute (ibs.GRANADA) has held a relevant scientific conference at the San Cecilio University Clinical Hospital, focused on advances in the multidisciplinary approach to prostate cancer. This event brought together almost a hundred healthcare professionals from Granada to discuss the latest advances in the diagnosis, treatment and management of this disease, with a clear focus on personalized precision medicine and interdisciplinary collaboration.
La Dr. María José Sánchez Pérez, scientific director of the ibs.GRANADA, has highlighted that “it is important to bring the new reality of personalized and precision medicine closer to the field of prostate cancer, since personalized medicine and the use of genetic profiling have meant a true revolution in the approach to this oncological pathology. This Conference is a unique opportunity to discuss the advances that the use of genetic profiling or genome has meant when it comes to allowing an individualized approach to the diagnosis, treatment and prevention of prostate cancer."
Throughout the day, key topics were addressed such as: diagnosis through genetic mutations and the use of genomic profiles, allowing for greater precision in the detection and treatment of prostate cancer. Speakers such as Dr. María José Serrano have highlighted the impact of personalized medicine in this field, while Dr. Ignacio Puche has presented new therapies based on the genetic characteristics of the tumor, highlighting their superiority over conventional treatments. This precision approach not only improves the identification of the disease, but also facilitates individualized treatment that better responds to the specific needs of each patient.
The role of real-world clinical data (Real World Evidence) in therapeutic decision-making was also highlighted. This data allows treatments to be adjusted based on experiences obtained in clinical practice, optimising results beyond clinical trials. In addition, the importance of therapeutic adherence in oncological treatment was highlighted, which is essential to guarantee the effectiveness of treatments and improve outcomes in patients with prostate cancer.
The event ended with the institutional closure in charge of Dr. Miguel Arrabal, Head of the Urology Department at the San Cecilio University Clinical Hospital, who emphasized that "collaboration between different specialties is essential for advancing the management of prostate cancer, and the integration of personalized medicine has radically changed the way we treat patients. We are facing a promising future in which decisions based on real, patient-specific data will improve clinical outcomes and quality of life."
With a broad participation and high-level scientific content, this conference has highlighted the importance of multidisciplinary collaboration and advances in precision medicine to improve the approach and treatment of prostate cancer.
About the ibs.GRANADA
The Instituto de Investigación Biosanitaria ibs.GRANADA, is the only center accredited by the Carlos III Health Institute (ISCIII) that develops biomedical research of excellence in Granada and one of the four accredited in Andalusia by the ISCIII.
The ibs.GRANADA is structured in four Scientific Areas: Oncology, Precision Medicine, Epidemiology and Public Health and Technology and Advanced Therapies that develop an intense research activity and lead the transfer of research results to society, which are reflected in the 1.210 publications made in scientific journals, totaling 6.668 impact factor points, as well as 19 patents applied for during 2023.
Currently, the Institute brings together 1.088 professionals and 69 multidisciplinary research groups that comprise, from the University of Granada, the Virgen de las Nieves University Hospital, the San Cecilio Clinical University Hospital, the Andalusian School of Public Health and the centers of Primary Care of Granada.
The main objectives of ibs.GRANADA are to promote biomedical, clinical and epidemiological research carried out by the different groups attached to the institute and to facilitate translational research in Granada hospitals. This research activity translates into the generation of knowledge and the transfer of scientific advances towards the prevention, diagnosis and treatment of priority health problems in Andalusia.
